[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355702-105":59,"doc-detail-355702-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","perioperative-outcomes-and-challenges-in-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-a-single-institution-case-series","Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy - A single-institution case series","","Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a high-risk, potentially curative treatment for peritoneal surface malignancies. A retrospective analysis evaluated perioperative outcomes and challenges from March 2023 to September 2025 at Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman. Data included demographics, intraoperative variables, and postoperative outcomes; 25 consecutive patients were analysed with statistical methods. Results showed significant comorbidities, metabolic stress, haemodynamic instability, and postoperative complications including coagulopathy and renal impairment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/perioperative-outcomes-and-challenges-in-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-a-single-institution-case-series/355702/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/perioperative-outcomes-and-challenges-in-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-a-single-institution-case-series/355702.png","ImageObject",300,407,{"name":92,"@type":93},"Nguyễn Văn Học","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What treatment does the case series evaluate?","Question",{"text":112,"@type":113},"The study evaluates cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What period and setting were included in the analysis?",{"text":117,"@type":113},"The retrospective analysis covered March 2023 to September 2025 at Sultan Qaboos Comprehensive Cancer Care and Research Centre in Muscat, Oman.",{"name":119,"@type":110,"acceptedAnswer":120},"How were perioperative outcomes and challenges assessed?",{"text":121,"@type":113},"Researchers collected data on demographics, intraoperative variables, and postoperative outcomes from electronic medical records, anaesthesia charts, and surgical reports, using a standardised extraction protocol and statistical analysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355702,1790146356,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},1374402739827,"https://ap-avatar.wpscdn.com/avatar/14000c97e7351f1a627?x-image-process=image/resize,m_fixed,w_180,h_180&k=1787885694763230660","SULTAN QABOOS UNIVERSITY MEDICAL JOURNAL 2026;26:276–283 Scan the QR to view  \nthe full-text article on the journal website  \nCASE REPORT  \nPerioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A single-institution case series  \nParli Raghavan Ravi a,*, Maha Abdullah Naseer AlShaibi b, Raj Sahajanandan a, Mohammed Abdullah Saif AlHosni b, Srinivas Shyam Mantha a  \na Department of Anaesthesiology, Sultan Qaboos Comprehensive Cancer Care and Research Centre, University Medical City, Muscat, Oman b Department of Oncosurgery, Sultan Qaboos Comprehensive Cancer Care and Research Centre, University Medical City, Muscat, Oman  \nABSTRACT  \nCytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) is a high-risk, but potentially curative, treatment for peritoneal surface malignancies. This retrospective analysis was conducted between March 2023 and September 2025 at Sultan Qaboos Comprehensive Cancer Care and Research Centre, Muscat, Oman, with the objective of analysing perioperative outcomes and challenges in patients undergoing CRS with HIPEC. Data on demographics, intraoperative variables and postoperative outcomes were collected and statistically analysed. A total of 25 consecutive patients were included. The cohort had signiﬁcant comorbidities (American Society of Anesthesiologists II/III D 84%). Signiﬁcant metabolic stress was evidenced by increased lactate (P \u003C0.001) and base deﬁcit (P \u003C0.05). Haemodynamic instability necessitated frequent vasopressor use (noradrenaline D 48%). Postoperatively, 20% developed coagulopathy and 16% renal impairment. Thoracic epidural analgesia was primary in 76% of cases. Prolonged ventilation (>5 days) was needed in 12% and the mortality rate was 8%(n D 2); however, this ﬁnding should be interpreted with caution given the limited sample size. Meticulous management of haemodynamics, metabolic stress and tailored multimodal analgesia is crucial. Outcomes align with established literature, underscoring the procedure's complexity and the need for optimised protocols to enhance patient safety.  \nKeywords: Cytoreductive Surgery; Hyperthermic Intraperitoneal Chemotherapy; Perioperative Care; Anesthesia; Postoperative Complications; Case Report; Oman  \n1. Introduction  \nCytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) has emerged as an important treatment strategy for peritoneal surface malignancies, oﬀering improved survival outcomes for selected patients. This aggressive surgical approach, while potentially curative, presents signiﬁcant perioperative challenges due to the extensive nature of the surgery, prolonged anaesthesia duration and systemic eﬀects of hyperthermic  \nchemotherapy. The procedure is associated with complex physiological derangements, including major ﬂuid shifts, haemodynamic instability, metabolic acidosis and coagulopathy. Despite advances in surgical and anaesthetic techniques, CRS-HIPEC remains a high-risk procedure with considerable morbidity. This report aimed to describe the perioperative course, quantify the incidence of key complications and analyse intraoperative physiological trends in patients undergoing CRS-HIPEC at a tertiary care cancer centre in Muscat, Oman. The authors'  \nReceived 23 September 2024; revised 7 January 2025; accepted 2 April 2026.  \nAvailable online 15 April 2026  \n* Corresponding author.  \nE-mail address: [parliravi@gmail.com](parliravi@gmail.com) (P. R. Ravi).  \n[https://doi.org/10.18295/2075-0528.2984](https://doi.org/10.18295/2075-0528.2984)  \n2075- 0528/© 2026 Published by Sultan Qaboos University Sultan Qaboos University Medical Journal. This is an open-access article under the CC BY-ND license ([https://creativecommons.org/licenses/by-nd/4.0/](https://creativecommons.org/licenses/by-nd/4.0/)).  \nhypothesise that the procedure induces signiﬁcant metabolic stress and haemodynamic instability correlating with surgical comple","cbCaio7RG2Sjuwbf","https://ap.wps.com/l/cbCaio7RG2Sjuwbf","pdf",261607,"English","# 1. Introduction\n# 2. Methods\n## Study design and setting\n## Patient selection and inclusion/exclusion\n## Data collection and variables","[{\"question\":\"What treatment does the case series evaluate?\",\"answer\":\"The study evaluates cytoreductive surgery (CRS) combined with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies.\"},{\"question\":\"What period and setting were included in the analysis?\",\"answer\":\"The retrospective analysis covered March 2023 to September 2025 at Sultan Qaboos Comprehensive Cancer Care and Research Centre in Muscat, Oman.\"},{\"question\":\"How were perioperative outcomes and challenges assessed?\",\"answer\":\"Researchers collected data on demographics, intraoperative variables, and postoperative outcomes from electronic medical records, anaesthesia charts, and surgical reports, using a standardised extraction protocol and statistical analysis.\"}]","Perioperative Outcomes and Challenges in Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy - A single-institution case series | PDF",1790120550,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/28c4b3f97205bba13c962a6e5cf0e789.webp",983,1310,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/da6b08ea3cf2ea98a593ab5d97fb8d45.webp",982,1309,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6a53e83980e5b7c39e982a94f77be76.webp",981,1308,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8fec8eb6447f3d230efa9fe5ac5668e7.webp",980,1306]